Sorry, specificity was strong, not sensitivity. "The new panel demonstrated a moderate sensitivity of 0.65 (CI: 0.524 to 0.758), and an impressive specificity of 0.976 (CI: 0.877 to 0.999)".
- Forums
- ASX - By Stock
- ATH
- Amyloid clearance by monocytes correlates with AD progression
ATH
alterity therapeutics limited
Add to My Watchlist
10.0%
!
0.9¢

Amyloid clearance by monocytes correlates with AD progression, page-7
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.9¢ |
Change
-0.001(10.0%) |
Mkt cap ! $82.14M |
Open | High | Low | Value | Volume |
1.0¢ | 1.0¢ | 0.9¢ | $57.39K | 6.030M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
59 | 20158607 | 0.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.0¢ | 6639574 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
61 | 21133607 | 0.009 |
24 | 37062186 | 0.008 |
22 | 66487963 | 0.007 |
15 | 8363518 | 0.006 |
6 | 3875001 | 0.005 |
Price($) | Vol. | No. |
---|---|---|
0.010 | 7705526 | 8 |
0.011 | 9447823 | 26 |
0.012 | 11153757 | 21 |
0.013 | 10585068 | 13 |
0.014 | 14148180 | 9 |
Last trade - 15.47pm 10/07/2025 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |